Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT

This study tests whether Rhopressa (netarsudil) eye drops can lower eye pressure in patients with glaucoma or ocular hypertension who have recently had a laser procedure called SLT (selective laser trabeculoplasty). **You may be eligible if...** - You are 18 or older - You have been diagnosed with glaucoma (open-angle type) or high eye pressure in both eyes - You recently completed SLT laser treatment in both eyes within the last 90 days - Your eye pressure is in a specific range (16–28 mmHg) **You may NOT be eligible if...** - You have had eye surgery (other than SLT) in the past 3 months - You are currently using other prescription eye pressure-lowering drops - You have only one functional eye - You have certain eye conditions like severe dry eye or corneal disease Talk to your doctor to see if this trial is right for you.